SHANGHAI, December 23, 2014 /PRNewswire/ -- Phagelux, Inc., a leading anti-bacterial company developing phage-based solutions, is pleased to announce the acquisition of several biodegradable polymer delivery systems from Iveria Technologies, Inc., a U.S.-based development company specializing in such technologies.
"The acquisition of these technologies from Iveria will allow us to deliver our phage-based antibacterial solutions either as stand-alone products or in combination with more established medicines," said Mark Engel, Chairman of Phagelux. "The latter should open up a series of licensing and co-development opportunities for our company."
About Phagelux, Inc.
Phagelux, Inc. is developing anti-bacterial solutions across multiple fields utilizing various phage and phage-based technologies. Phagelux is headquartered in Shanghai, with laboratories in China and North America.
Media Contact
Dr. Sixiang Zhou
Director of Business Development
+86-21-6150-0300
zhousx@phagelux.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/phagelux-announces-acquisition-of-novel-delivery-systems-300013532.html
